Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Terence, Tan"'
Autor:
Victor Ho-Fun Lee, Lillian L. Siu, Harry H.Y. Yiu, To-Wai Leung, Anne W.M. Lee, Brian O'Sullivan, Horace C.W. Choi, Terence Tan, Wai Tong Ng, Lucy L.K. Chan, Tai Xiang Lu, Roger K.C. Ngan, Alice W.Y. Ng, Eng Huat Tan, Henry C.K. Sze, Stewart Y. Tung, Rick Chappell
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 101:1078-1086
Purpose This is an updated combined analysis of 2 randomized studies (NPC-9901 and NPC-9902 trials) to evaluate the 10-year outcome attributed to the addition of concurrent-adjuvant chemotherapy for advanced locoregional nasopharyngeal carcinoma (NPC
Autor:
Ashik Hussain, Terence Tan, Whee Sze Ong, Yoke Lim Soong, Joseph Wee, Kam Weng Fong, Kiattisa Sommat
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 98:574-580
Purpose Primary hypothyroidism (HT) is a common occurrence after intensity modulated radiotherapy (IMRT) for nasopharyngeal carcinoma (NPC). The aim of this study is to investigate the various clinical and thyroid dosimetric parameters that could pre
Autor:
Huiyu Low, Jess Honganh Vo, Terence Tan, Belinda Ling, Wen Long Nei, Lynette Oon, Kiattisa Sommat, Fuqiang Wang, Johnson Ng, Wai Min Phyo, Min Hu, Kam Weng Fong, Wan Loo Tan, Yoke Lim Soong, Kian Sing Chan, Jackie Y. Ying, Shie Lee Cheah, Min-Han Tan
Publikováno v:
Scientific Reports
Scientific Reports, Vol 6, Iss 1, Pp 1-9 (2016)
Scientific Reports, Vol 6, Iss 1, Pp 1-9 (2016)
Quantification of Epstein-Barr virus (EBV) cell-free DNA (cfDNA) is commonly used in clinical settings as a circulating biomarker in nasopharyngeal carcinoma (NPC), but there has been no comparison with circulating tumour cells (CTCs). Our study aims
Autor:
Lucy L.K. Chan, Wai Tong Ng, Lillian L. Siu, Brian O'Sullivan, Roger K.C. Ngan, Eng Huat Tan, Chong Zhao, Daniel T.T. Chua, Wai Hon Lau, Yiu-Tung Fu, Anne W.M. Lee, Gordon K.H. Au, Stewart Y. Tung, Terence Tan, Rick Chappell, To-Wai Leung, Taixiang Lu
Publikováno v:
European Journal of Cancer. 47:656-666
Background The current standard treatment for locoregionally advanced nasopharyngeal carcinoma (NPC) was conventional–fractionation radiotherapy plus concurrent–adjuvant chemotherapy as recommended by the Intergroup-0099 Study. This combined anal
Publikováno v:
Head & Neck. 31:1610-1618
Background. The aim of this study was to review our experience and demonstrate the safety of intracavitary brachytherapy (ICB) in patients with nasopharyngeal carci- noma (NPC). Methods. Hundred seventy-eight patients with early T1-2b disease underwe
Autor:
Shirley L. Xu, Jonathan S.T. Sham, Rick Chappell, Xiu Fang Liu, Ellie S.Y. Pang, To-Wai Leung, Stewart Y. Tung, Wing Hong Kwan, Tai Xiang Lu, Eng Huat Tan, Lillian L. Siu, Terence Tan, Yiu Tong Fu, Daniel T.T. Chua, Wai Hon Lau, Wai Man Sze, Anne W.M. Lee, Anthony T.C. Chan, Brian O'Sullivan, Paddy T M Chan
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 66:142-151
To compare the benefit achieved by concurrent chemoradiotherapy (CRT) and/or accelerated fractionation (AF) vs. radiotherapy (RT) alone with conventional fractionation (CF) for patients with T3-4N0-1M0 nasopharyngeal carcinoma (NPC).All patients were
Autor:
Shie-Lee Cheah, Joseph Wee, Daniel Tan, Connie Yip, Daniel Quah, Mei-Kim Ang, Khee Chee Soo, Kam Weng Fong, Yoke-Lim Soong, Terence Tan, Sze Huey Tan, Whee-Sze Ong, Quan Sing Ng, Wan-Teck Lim
Publikováno v:
International journal of radiation oncology, biology, physics. 91(5)
Purpose To compare survival, tumor control, toxicities, and quality of life of patients with locally advanced nasopharyngeal carcinoma (NPC) treated with induction chemotherapy and concurrent chemo-radiation (CCRT), against CCRT alone. Patients and M
Autor:
Hwee Bee Wong, Kam Weng Fong, Lee Ks, Vijay K Sethi, Swan Swan Leong, Eu Jin Chua, David Machin, Eu Tiong Chua, Bee Choo Tai, Terence Tan, Edward Yang, Hoon Seng Khoo Tan, Eng Huat Tan, Khai Mun Lee, Joseph Wee, Susan Loong
Publikováno v:
Journal of Clinical Oncology. 23:6730-6738
Purpose The Intergroup 00-99 Trial for nasopharyngeal cancer (NPC) showed a benefit of adding chemotherapy to radiotherapy. However, there were controversies regarding the applicability of the results to patients in endemic regions. This study aims t
Autor:
Y. K. Ong, Joseph Wee, B. Chung, S. S. Leong, Kam Weng Fong, E. H. Tan, Terence Tan, D. M. Heng
Publikováno v:
European Journal of Cancer. 39:1535-1541
The survival outcome of patients with systemic cancer differs significantly between individuals even within the same tumour type. We set out to illustrate this by analysing the factors determining survival in patients with metastatic disease from nas
Autor:
Eu J Chua, Joseph Wee, Eng H. Tan, Peng T. Ang, Yew Kwang Ong, Eu T Chua, Lee Ks, Vijay K Sethi, K.W. Fong, Khai Mun Lee, Hoon S. Khoo-Tan, Kian Fong Foo, Terence Tan, Swan S. Leong
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 45:597-601
Purpose: Nasopharyngeal carcinoma (NPC) is endemic in Singapore. Nearly 60% of the patients diagnosed with NPC will present with locally advanced disease. The North American Intergroup study 0099 reported improved survival outcome in patients with lo